Cognitive enhancers-drugs taken to enhance concentration, memory, alertness, and moods- that are often given to patients with Alzheimer’s disease do not improve cognition or function for those with mild cognitive impairment (MCI) in the long term-about 96 weeks, according to a study published recently in the Canadian Medical Association Journal.
A new poll sent to independent compounding pharmacies by the Professional Compounding Centers of America (PCCA) found that approximately 40% of pharmacies surveyed would close their businesses under the requirements of Senate Bill 959, The Pharmaceutical Quality, Security, and Accountability Act.
An independent pharmacist has created a subscription-based website that he believes can help consumers save money by disclosing the wholesale cost of prescriptions.
FDA has approved ustekinumab (Stelara, Janssen Biotech) alone or in combination with methotrexate for active psoriatic arthritis in adult patients aged 18 years and older.
The American Pharmacists Association Foundation has published a white paper on a prescription synchronization program for improved medication adherence and produced a tool kit for implementation.
Some women who take tamoxifen to treat or prevent breast cancer report experiencing a mental fogginess while on the drug, and researchers have now confirmed that there’s a biological basis for those symptoms, according to a study published online Sept. 17, 2013, in the Journal of Neuroscience.
WellTransitions program helps improve health outcomes and lower hospital rates of hospital readmission through inpatient counseling and medication reconciliation provided by Walgreens pharmacists.
Varenicline may be a helpful smoking-cessation aid to stable depressed patients already receiving antidepressants or anti-anxiety medications, and its use does not appear to worsen moods, thoughts, or emotional states.
Three of the largest health systems in New Jersey and four in Pennsylvania, totaling 25 hospitals, have formed an interstate consortium to work on quality, population health management, best practices, and medical research, according to a press statement from one of the health systems.
FDA is requiring color changes to the printing on fentanyl (Duragesic) pain patches so that it is clearly visible, to help avoid risk of accidental exposure.
The Office of Disease Prevention and Health Promotion under the Department of Health and Human Services (HHS) is calling for public review and comments on its draft plan to reduce adverse drug events that are preventable. The deadline is Friday, Oct. 4 to email feedback to [email protected].
Pharmacists throughout California are a signature away from being able to give a full range of immunizations, as well as dispensing birth control pills and certain medications for international travel.
A new report by the U.S. Centers for Disease Control and Prevention says millions of Americans are at risk from drug-resistant superbugs that cause gonorrhea, C. difficile, and carbapenem-resistant Enterobacteriaceae.
FDA has issued an import alert authorizing border control officials to detain drug products manufactured at Ranbaxy Laboratories, Ltd.’s facility in Mohali, India. The agency said action is warranted because Ranbaxy is not complying with U.S. manufacturing requirements.
Walgreens has joined a growing list of companies that will soon provide subsidies to employees who, in turn, will select their health insurance coverage through a private exchange.
A coalition that includes pharmacy-advocacy groups has endorsed legislation it says will bring fairness and integrity to the Medicare Part D pharmacy program.
A coalition that includes the Maine Pharmacy Association has sued that state to stop a new law that allows consumers to buy mail-order prescription drugs from unlicensed international firms.
Managed Health Care Associates, Inc. has partnered with CoverMyMeds to launch MHAuthorizeRx, a web-based tool designed to help pharmacies collaborate with physicians in submitting prior authorizations to health plans.
Study author says blood-pressure control program's remarkable success keeps growing - and can be replicated.
Pharmacists take heat every day from belligerent patients and bullying managers - because they allow it. Here are three words: Corporate Compliance Officer.
While FDA has done little to combat tobacco use, manufacturers are targeting young African Americans with saturation advertising, using menthol cigarettes as bait.
When frightened girls come back from emergency trips to Mexico and ask you how to use an off-label drug as an "abortion pill," what are you going to tell them?
The entire multidisciplinary healthcare team can be compared to a football team. And pharmacists are called upon to play several positions.
With the flu season right around the corner, pharmacies should engage payers as early in the year as possible to ensure adequate time to finalize contracting, fully test their billing capabilities, and stock inventory before the official start of the vaccine season.
Massachusetts' Harvard Pilgrim Health Care has instituted a policy shift excluding coverage of prescription drugs compounded for adults. Plaintiffs call this "a callous decision" and "a major blow" to the state's many patients who depend on compounded medications.
A new survey of U.S. neurologists indicates that one-fifth have not been aware of FDA safety alerts connected with anti-seizure drug therapies.
A look at upcoming Continuing Pharmacy Education units on osteoporosis, multiple sclerosis, and cardiometabolic syndrome.
As a healthcare model, the PCMH is a work in progress, but all signs point to its increasing importance. And pharmacists are key members of the team.
Numerous studies have concluded that the risk of influenza vaccination leading to Guillain-Barre syndrome is slim indeed. To see the odds, read on.
Indianapolis pharmacists and the college of pharmacy at Butler University brainstorm solutions to the problem of medication adherence in a live CE program.